Related Experiment Videos
Functional changes in brain activity during priming in Alzheimer's disease
L Bäckman1, O Almkvist, L Nyberg
1Uppsala University, Stockholm Gerontology Research Center, and Karolinska Institute, Sweden.
Journal of Cognitive Neuroscience
|April 19, 2000
Summary
Alzheimer's disease patients show impaired implicit memory, specifically word-stem completion priming. Brain imaging reveals abnormal posterior neocortex activity in Alzheimer's disease during this task.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Neurology
Background:
- Alzheimer's disease (AD) is characterized by deficits in implicit memory, including word-stem completion priming (WSCP).
- Previous lesion studies implicated the posterior neocortex in WSCP deficits observed in AD.
- The precise neural mechanisms underlying WSCP impairment in AD remain incompletely understood.
Purpose of the Study:
- To investigate the neural correlates of word-stem completion priming (WSCP) in Alzheimer's disease (AD) patients using positron emission tomography (PET).
- To compare brain activity during WSCP between AD patients and healthy older adults.
Main Methods:
- Positron emission tomography (PET) was employed to measure brain activity.
- Participants included patients with Alzheimer's disease and normal older adults.
- A word-stem completion priming task was administered during PET scanning.
Main Results:
- Alzheimer's disease patients exhibited reduced priming effects compared to normal older adults.
- Normal older adults demonstrated decreased activity in the right occipital cortex (area 19) during priming.
- AD patients showed increased activity in the right occipital cortex (area 19) during priming.
Conclusions:
- The findings provide direct evidence linking abnormal posterior neocortical function to WSCP deficits in AD.
- Altered activity patterns in the right occipital cortex during priming suggest slower neuronal shaping in AD.
- Inadequate initial stimulus processing may contribute to the observed neuronal activity differences in Alzheimer's disease.